Abstract
The phasing-out of an SV40 cross-reactive fetal antigen in the developing hamster fetus after day 10 occurs concomitantly with an increase of bound sialic acid in membrane, microsomal and soluble cell fractions1. A masking phenomenon is suggested by the fact that the antigen can be uncovered on older fetal tissue by trypsinisation2. Similarly, a murine oncofetal antigen under study in our laboratory is optimally expressed on the haematopoietic stem cells of the fetal liver at the 15th day of gestation3, just before the onset of haematopoiesis and collagen production in the spleen4. The expression of this antigen on human leukaemic blast cells has, furthermore, been correlated with low levels of sialic acid on the surface of these tumour cells5. As fetal determinants can be expressed on adult bone marrow in disease states not involving malignant transformation6, it is of interest to know whether production of this oncofetal antigen is repressed, or whether the determinants are in cryptic form at the plasma membrane due to some masking phenomenon. The investigation described here demonstrates that determinants which cross-react immunologically with fetal liver tissue can be enzymatically unmasked on normal adult murine haematopoietic stem-cell surfaces. This finding suggests that the expression of these oncofetal antigens on malignant cells does not depend on de novo production of the antigens, and that these determinants may play some part in normal differentiation control mechanisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hannon, W. H., Anderson, N. G. & Coggin, J. H. Jr in Chemical Carcinogenesis B (eds Di Paolo, J.A. & Ts'O, P.O.P.) 669–684 (Dekker, New York, 1974).
Girardi, A. J. & Repucci, P. in Embryonic and Fetal Antigens in Cancer Vol. 2 (eds Anderson, N.G. & Coggin, J.H.Jr) 167–70 (US Department of Commerce, Springfield, 1972).
Salinas, F. A., Smith, J. A. & Hanna, M. G. Jr Nature 240, 41–43 (1972).
Djaletti, M., Bessler, H. & Rifkind, R. A. Blood 39, 826–841 (1972).
Granatek, C. H. et al. Cancer Res. 36, 3464–3470 (1976).
Lewis, M. G., Sheikh, K. M., Avis, P., Whitehead, V. M. & Vera, C. Differentiation 2, 307–311 (1974).
Dicke, K. A., van Noord, M. J., Shaefer, U. W. & van Bekkum, D. W. Blood 42, 195–208 (1973).
Granatek, C. H., Corry, P. M. & Goldin, E. M. Proc. Am. Ass. Cancer Res. 16, 47 (1975).
Goldin, E. M., Corry, P. M. & Granatek, C. H. Biochem. biophys. Acta 552, 120–128 (1979).
Lewis, M. G., Rowden, G., Sheikh, K. M. & Summerlin, W. T. Differentiation 3, 149–154 (1975).
Thorpe, W. P., Parker, G. A. & Rosenberg, S. A. J. Immun. 119, 818–823 (1977).
Parker, G. A., Hyatt, C. & Rosenberg, S. A. Transplantation 23, 161–163 (1977).
Salinas, F. A. & Hanna, M. G. Jr J. Immun. 112, 1026–1034 (1974).
Chism, S. E., Wallis, S., Burton, R. & Warner, N. L. J. Immun. 117, 1870–1877 (1976).
Prager, D. M., Granatek, C. H. & Ludden, C. M. Israel J. med. Sci. 12, 325–333 (1976).
Granatek, C. H. & Hanna, M. G. Jr Proc. Am. Ass. Cancer Res. 15, 31 (1974).
Granatek, C. H., Hersh, E. M., Gutterman, J. U. & Mavligit, G. M. Eur. J. Cancer 13, 999–1007 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Granatek, C., Scheinberg, B. & Corry, P. Unmasking of fetal determinants on adult bone marrow cells. Nature 281, 484–485 (1979). https://doi.org/10.1038/281484a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/281484a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.